RAP 0.00% 20.5¢ raptor resources limited

Ann: ResApp Builds European Market Presence, page-45

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
  1. 2,574 Posts.
    lightbulb Created with Sketch. 4962
    It's not the case fat ring up management or email and they will explain it to you in detail. They are hoping to use our product IMO they approached US, they like what we have, perhaps the consumer healthcare market device may even require regulatory clearance? Lots of stuff going on behind the scenes that we don't know about so I wouldn't jump to any conclusion stating that they have simply abandoned us and don't want to use our product it's simply not the case..

    Regarding the hospital trials it's nothing like the US double blind hospital trials. These kinds of trials that are going to be conducted in various hospitals throughout Europe for kids and adults. They are simply testing the softwares ability in terms of time management cost effectiveness etc. To me it's obvious that our device will have a huge Positive Impact within this type of setting..

    Cheers

    Red bar
    Last edited by Red bar: 26/03/20
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.